Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002749

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 27, 2016
Accepted (ET)
Mar 29, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 8, 2018S10,000$9.12D2,146,797ISee footnote
Common StockF1,F2Mar 12, 2018S18,560$9.50D2,128,237ISee footnote
Common StockF1,F2Mar 13, 2018S16,934$9.27D2,111,303ISee footnote
Common StockF1,F2Mar 14, 2018S13,600$9.47D2,097,703ISee footnote
Common StockF1,F2Mar 16, 2018S6,423$9.52D2,091,280ISee footnote
Common StockF1,F2Mar 16, 2018S2,120$9.52D2,089,160ISee footnote
Common StockF3Mar 16, 2018S2,120$9.52D1,672,494D
Common StockF1,F2Mar 19, 2018S200$9.57D2,088,960ISee footnote
Common StockF3Mar 19, 2018S200$9.57D1,672,294D
Common StockF1,F2Mar 20, 2018S4,200$9.54D2,084,760ISee footnote
Common StockF3Mar 20, 2018S4,200$9.54D1,668,094D
Common StockF1,F2Mar 20, 2018S15,183$9.70D2,069,577ISee footnote
Common StockF3Mar 20, 2018S15,183$9.70D1,652,911D
Common StockF1,F2Mar 21, 2018S210,311$10.18D1,859,266ISee footnote
Common StockF3Mar 21, 2018S210,311$10.18D1,442,600D
Common StockF1,F2Mar 22, 2018S20,000$10.76D1,839,266ISee footnote
Common StockF3Mar 22, 2018S20,000$10.76D1,422,600D
Common StockF1,F2Mar 23, 2018S3,500$10.88D1,835,766ISee footnote
Common StockF3Mar 23, 2018S3,500$10.88D1,419,100D
Common StockF1,F2Mar 27, 2018S22,707$11.34D1,813,059ISee footnote
Common StockF3Mar 27, 2018S22,707$11.34D1,396,393D
Common StockF1,F2Mar 28, 2018S605$11.65D1,812,454ISee footnote
Common StockF3Mar 28, 2018S605$11.65D1,395,788D
Common StockF1,F2Mar 28, 2018S145,788$11.50D1,666,666ISee footnote
Common StockF3Mar 28, 2018S145,788$11.50D1,250,000D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This is the fourth part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.